Figure 6.
Schematic illustration of various subcellular targeted NPs for improved PDT-driven cancer immunotherapy. (A) ER-targeting Ds-sP/TCPP-TER NPs, (B) Ce6-loaded mitochondrial-targeting NPs, (C) enzyme-driven PM-targeting PCPK NPs. Reproduced with permission 118, 87, 120. Copyright 2020, American Chemical Society; Copyright 2018, American Chemical Society; Copyright 2019, American Chemical Society.